UAE's bold 'Make it in the Emirates' strategy seeks to elevate manufacturing sector, attracting global investment and ...

There’s no myth behind Daymond John’s success. The founder of FUBU turned a $40 hustle into a global fashion empire and went ...

Marc Frahm, an analyst at TD Cowen, downgraded Blueprint Medicines Corporation (NASDAQ:BPMC) from Buy to Hold. This ...

Something that still surprises us when meeting with potential clients are their expectations on timelines for planning and ...

Jose Munoz discuses the Mega Trends impacting the future of mobility, his vision for making Hyundai the leader in both ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

“Agentic Process Fabric… allows enterprises to build a registry of all of their workflows, existing systems, existing ...

Sanofi SNY announced that it has entered into a definitive agreement to acquire Blueprint Medicines BPMC for a total deal ...

Pega is taking a contrarian approach to enterprise AI agents, arguing that workflow-based automation is more reliable than ...

The French drugmaker will pay up to $9.5 bln for Blueprint Medicines, whose key product fights skin rashes. It eases CEO Paul ...

Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare arm ...

Sanofi agreed to buy Blueprint Medicines, a U.S. pharmaceutical company that specializes in rare immunological diseases, for up to $9.5 billion in a deal that seeks to strengthen the French ...